Surgical Treatment of Nasal Polyposis

  • Şenol Çomoğlu
  • Nesil Keleş
  • James Palmer


Modern endonasal surgery that is widely being performed in the world today has been developed and transformed for more than 100 years. Numerous physiologists, anatomists, and surgeons such as Grünwald, Hilding, Killian, van Alyea, Hayek, Ingal, Moscher, and Onodi have paved the way for this development. In the first period of endonasal approach, complication rates were high related to limited view and lack of comprehensive anatomical knowledge. Nasal polyposis (NP) constitutes the subgroup of one-fifth of patients with chronic rhinosinusitis accompanying a more intense mucosal inflammation and more frequent relapse. Surgical and medical treatments or almost both treatments have a part in the treatment of NP. Nevertheless, the content, timing, and duration of treatment are contradictive. NP may be considered as a consequence of common phenotype generated in the nasal mucosa of many diseases or pathological processes, and the medical approach is basically paramount for treatment. Surgical treatment is used for patients who have resistance to maximal medical treatment and who are not able to use systemic steroid and for those with massive nasal polyposis with advanced nasal congestion. This treatment indicates a spectrum extending from simple polypectomy to radical “nasalization.” The most widespread surgical approach is “functional endoscopic sinus surgery” (FESS). There is no completely curative surgical method and the relapse rate is high. The main goals of FESS are to clean polyps and the polypoid mucosa, to increase ventilation by opening the sinus ostia, heal mucociliary clearance, and provide paranasal physiologic restoration. Furthermore, FESS states an approach rather than operation that can be standardized and it is quite difficult to do a randomized controlled study that is able to evaluate the results for NP treatment due to several reasons. In the surgical treatment of NP, FESS has supplanted conventional methods or techniques at the present time.


Nasal polyposis Functional endoscopic sinus surgery Treatment Increase ventilation Paranasal physiologic restoration 


  1. 1.
    Kennedy DW, Zinreich SJ, Rosenbaum AE, et al. Functional endoscopic sinus surgery. Theory and diagnostic evaluation. Arch Otolaryngol. 1985;111:576–82.PubMedGoogle Scholar
  2. 2.
    Stammberger H. Functional endoscopic sinus surgery. Philadelphia: BC Decker; 1991.Google Scholar
  3. 3.
    Wigand ME. Endoscopic surgery of the paranasal sinuses and anterior skull base. Stuttgart: Thieme; 1990.Google Scholar
  4. 4.
    Poetker DM, Mendolia-Loffredo S, Smith TL. Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol. 2007;21(1):84–8.PubMedGoogle Scholar
  5. 5.
    Bhattacharyya N. Influence of polyps on outcomes after endoscopic sinus surgery. Laryngoscope. 2007;117(10):1834–8.PubMedGoogle Scholar
  6. 6.
    Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope. 2004;114(5):811–3.PubMedGoogle Scholar
  7. 7.
    Brescia G, Marioni G, Franchella S, et al. A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2016;273(3):655–60.PubMedGoogle Scholar
  8. 8.
    Sharma R, Lakhani R, Rimmer J, et al. Surgical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014:CD006990.
  9. 9.
    Rimmer J, Fokkens W, Chong LY, et al. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;
  10. 10.
    Radenne F, Lamblin C, Vandezande LM, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol. 1999 Jul;104(1):79–84.PubMedGoogle Scholar
  11. 11.
    Alonso J, Prieto L, Ferrer M, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol. 1998 Nov;51(11):1087–94.PubMedGoogle Scholar
  12. 12.
    Failde I, Ramos I. Validity and reliability of the SF-36 health survey questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000;53(4):359–65.PubMedGoogle Scholar
  13. 13.
    Espinosa De Los Monteros MJ, Alonso J, Ancochea J, et al. Quality of life in asthma: reliability and validity of the short form generic questionnaire (SF-36) applied to the population of asthmatics in a public health area. Arch Bronconeumol. 2002;38(1):4–9. SpanishPubMedGoogle Scholar
  14. 14.
    Alobid I, Benítez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy. 2005;60(4):452–8.PubMedGoogle Scholar
  15. 15.
    Lildholdt T, Rundcrantz H, Bende M, et al. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg. 1997;123(6):595–600.Google Scholar
  16. 16.
    Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004;114(5):923–30.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Hopkins C, Browne JP, Slack R, et al. The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Clin Otolaryngol. 2006;31(5):390–8.PubMedGoogle Scholar
  18. 18.
    Ragab SM, Lund VJ, Scadding G, et al. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology. 2010;
  19. 19.
    Lildholdt T, Fogstrup J, Gammelgaard N, et al. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol. 1988;105(1-2):140–3.PubMedGoogle Scholar
  20. 20.
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111(5):913–21. quiz 922Google Scholar
  21. 21.
    Zhang Z, Adappa ND, Doghramji LJ, et al. Quality of life improvement from sinus surgery in chronic rhinosinusitis patients with asthma and nasal polyps. Int Forum Allergy Rhinol. 2014; Scholar
  22. 22.
    Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope. 2003 Oct;113(10):1703–6.Google Scholar
  23. 23.
    Ehnhage A, Olsson P, Kölbeck KG, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy. 2009; Scholar
  24. 24.
    Jankowski R, Pigret D, Decroocq F, et al. Comparison of radical (nasalisation) and functional ethmoidectomy in patients with severe sinonasal polyposis. A retrospective study. Rev Laryngol Otol Rhinol. 2006;127(3):131–40.Google Scholar
  25. 25.
    Masterson L, Tanweer F, Bueser T, et al. Extensive endoscopic sinus surgery: does this reduce the revision rate for nasal polyposis? Eur Arch Otorhinolaryngol. 2010; Scholar
  26. 26.
    Marchioni D, Alicandri-Ciufelli M, Mattioli F, et al. Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis. Acta Otolaryngol. 2008; Scholar
  27. 27.
    Wu AW, Ting JY, Platt MP, et al. Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience. Laryngoscope. 2014; Scholar
  28. 28.
    Soler ZM, Hwang PH, Mace J, et al. Outcomes after middle turbinate resection: revisiting a controversial topic. Laryngoscope. 2010; Scholar
  29. 29.
    Choby GW, Hobson CE, Lee S, et al. Clinical effects of middle turbinate resection after endoscopic sinus surgery: a systematic review. Am J Rhinol Allergy. 2014;
  30. 30.
    Kuehnemund M, Lopatin A, Amedee RG, et al. Endonasal sinus surgery: extended versus limited approach. Am J Rhinol. 2002;16(4):187–92.PubMedGoogle Scholar
  31. 31.
    Wadwongtham W, Aeumjaturapat S. Large middle meatal antrostomy vs. undisturbed maxillary ostium in the endoscopic sinus surgery of nasal polyposis. J Med Assoc Thail. 2003;86(Suppl 2):S373–8.Google Scholar
  32. 32.
    Seiberling K, Ooi E, MiinYip J, et al. Canine fossa trephine for the severely diseased maxillary sinus. Am J Rhinol Allergy. 2009; Scholar
  33. 33.
    Sathananthar S, Nagaonkar S, Paleri V, et al. Canine fossa puncture and clearance of the maxillary sinus for the severely diseased maxillary sinus. Laryngoscope. 2005;115(6):1026–9.PubMedGoogle Scholar
  34. 34.
    Lee JY, Lee SH, Hong HS, et al. Is the canine fossa puncture approach really necessary for the severely diseased maxillary sinus during endoscopic sinus surgery? Laryngoscope. 2008; Scholar
  35. 35.
    Bassiouni A, Wormald PJ. Role of frontal sinus surgery in nasal polyp recurrence. Laryngoscope. 2013; Scholar
  36. 36.
    Chan Y, Melroy CT, Kuhn CA, et al. Long-term frontal sinus patency after endoscopic frontal sinusotomy. Laryngoscope. 2009; Scholar
  37. 37.
    Friedman M, Bliznikas D, Vidyasagar R, et al. Long-term results after endoscopic sinus surgery involving frontal recess dissection. Laryngoscope. 2006;116(4):573–9.PubMedGoogle Scholar
  38. 38.
    Naidoo Y, Bassiouni A, Keen M, et al. Risk factors and outcomes for primary, revision, and modified Lothrop (Draf III) frontal sinus surgery. Int Forum Allergy Rhinol. 2013; Scholar
  39. 39.
    Ting JY, Wu A, Metson R. Frontal sinus drillout (modified Lothrop procedure): long-term results in 204 patients. Laryngoscope. 2014; Scholar
  40. 40.
    Georgalas C, Hansen F, Videler WJ, et al. Long terms results of Draf type III (modified endoscopic Lothrop) frontal sinus drainage procedure in 122 patients: a single Centre experience. Rhinology. 2011;
  41. 41.
    Anderson P, Sindwani R. Safety and efficacy of the endoscopic modified Lothrop procedure: a systematic review and meta-analysis. Laryngoscope. 2009; Scholar
  42. 42.
    Vlaminck S, Vauterin T, Hellings PW, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy. 2014;
  43. 43.
    Dalziel K, Stein K, Round A, et al. Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness. Am J Rhinol. 2006;20(5):506–19. ReviewPubMedGoogle Scholar
  44. 44.
    Suzuki S, Yasunaga H, Matsui H, et al. Complication rates after functional endoscopic sinus surgery: analysis of 50,734 Japanese patients. Laryngoscope. 2015; Scholar
  45. 45.
    Albu S, Tomescu E, Mexca Z, et al. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg. 2004;58(1):79–86.PubMedGoogle Scholar
  46. 46.
    Ottaviano G, Cappellesso R, Mylonakis I, et al. Endoglin (CD105) expression in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2015; Scholar
  47. 47.
    Tosun F, Arslan HH, Karslioglu Y, et al. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Ann Otol Rhinol Laryngol. 2010;119(7):455–9.PubMedGoogle Scholar
  48. 48.
    Mendelsohn D, Jeremic G, Wright ED, et al. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162–6.PubMedGoogle Scholar
  49. 49.
    Van Zele T, Holtappels G, Gevaert P, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014;
  50. 50.
    Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis. Rhinology. 2011;

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Şenol Çomoğlu
    • 1
  • Nesil Keleş
    • 1
  • James Palmer
    • 2
  1. 1.Istanbul Faculty of Medicine, Department of OtorhinolaryngologyIstanbul UniversityIstanbulTurkey
  2. 2.ENT DepartmentPerelman School of Medicine, University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations